NM Magazine logo

Author: mkk256

  • United in a Global Pandemic

    United in a Global Pandemic

    In recent months, we have experienced an unprecedented time in the history of Northwestern Medicine. The emergence of COVID-19 has required the collective response of our dedicated physicians, nurses, and support personnel, along with our scientists, trainees, and students. Together, we share incredible pride in the collective efforts of so many. The pandemic has demanded…

  • Meeting the Moment

    Meeting the Moment

    photography by LAURA BROWN Northwestern Medicine builds an immediate response. From the beginning of the pandemic, Northwestern Medicine deployed a number of tactics to help ensure the highest level of safety is in place for physicians, staff, patients, and visitors — as well as the community. Infectious disease specialist Gary Noskin, MD, senior vice president…

  • New Space, Enhanced Discovery

    New Space, Enhanced Discovery

    Research footprint grows by 10,000 square feet with outpatient facilities, core lab, enhanced support As Northwestern investigators continue to increase the breadth and widen the impact of clinical research, Northwestern Medicine has opened a new 10,000 square foot Clinical Research Hub to enhance investigative scope and infrastructure while improving participant experiences. Following a ceremonial ribbon…

  • Speaking Out on Disparities in NIH Funding

    Speaking Out on Disparities in NIH Funding

    Despite recent NIH findings showing that health disparities research and underrepresented minority scientists lack significant federal funding, the scientific community “has not embraced the message,” blocking progress towards health equity, according to a recent Northwestern Medicine editorial published in the Journal of the American Medical Association. The article was co-written by Mercedes Carnethon, PhD, the…

  • Top Honors for Clinical Research

    Top Honors for Clinical Research

    Northwestern University scientists received top honors from the Clinical Research Forum as part of its 2020 Top Ten Clinical Research Achievement Awards program, taking home the association’s highest honor and capturing more finalist nominations than any other institution. “The remarkable success of these brilliant and dedicated investigators shows the strength and breadth of Northwestern’s clinical…

  • Celebrating Feinberg’s 2020 Residency Match

    On Friday, March 20, a handful of fourth-year medical students gathered in a Chicago apartment, eagerly awaiting a life-changing moment. At exactly 11:00am, they ripped their cell phones from envelopes — a nod towards the match ritual of previous years — and logged on to a portal where they learned their match. “I would have…

  • Meet the Class of 2020

    For Patricia Obiageliaku Ekwueme, ’20 MD, ’20 MPH, graduating from medical school was a bittersweet ending to what was already a tough goodbye. “I’m so excited to conclude this chapter and take on a position where I can put these clinical skills I’ve learned to use,“ Ekwueme said. “But on the other hand, medical school…

  • Feinberg Among the Best

    Northwestern University Feinberg School of Medicine was recognized as one of the best research-oriented medical schools in the nation, rising one spot to rank 18th, according to the latest U.S. News & World Report rankings, released today. This is the 13th year in a row Feinberg has placed in the top 20 of research-oriented medical…

  • Progress Notes

    Progress Notes

    1940s Daniel Marshall, ’47 MD, was the 2018 recipient of the American College of Physicians’ Henry Gift Award. The award recognizes a Connecticut-based internist distinguished for a “lifetime of service to the care of patients and active participation in the local medical community.” Marshall retired in October 2018 after being in practice for six decades.…

  • New Genetic Regulators Could Improve Cancer Immunotherapy

    New Genetic Regulators Could Improve Cancer Immunotherapy

    A genetic screen has revealed previously unknown regulators of Foxp3, a transcription factor that, when deactivated, may improve patient response to aggressive cancers.